Navigation Links
ASA in Medical Technology

New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients

Aggrenox® (Asasantin® Retard) considered by many as first-line in secondary stroke prevention INGELHEIM, Germany, 31 May 2007 - New data presented today at the 16th European Stroke Conference in Glasgow confirm that therapy with dipyridamole plus ASA (extended-release dipyridamole plus...

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product

...with a three-fold higher risk of major CV events,(4A) which can occur within just 1-2 weeks of discontinuation.(4B) Up to 1 in 3 patients on low-dose asa may develop upper GI symptoms.(5A,6A) AstraZeneca conducted two studies to evaluate the safety and efficacy of NEXIUM in reducing the risk of gas...

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

...haradin to Treat Bone Metastases in Major Cancer Indications Algeta asa (OSE: ALGETA), the cancer therapeutics company, announces that with the res...ick on the ALSYPMCA link in the menu bar. About Algeta Algeta asa is a cancer therapeutics company built on world-leading, proprietary techno...

Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test

...rate Test's Potential for Rapid Uptake OSLO and FOSTER CITY, California, November 10 /PRNewswire-FirstCall/ -- DiaGenic asa (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI ) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cance...

Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting

... after the surgery. Therefore, modulating temperature becomes a very important tool in the physician's armamentarium. The cases being presented at the asa underscore the utility of temperature management for these situations." Various factors contribute to hypothermia during surgery, including the type...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

...urvival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced t... Research and the Royal Marsden Hospital in the UK. About Algeta Algeta asa is a Norwegian cancer therapeutics company built on world-leading, propriet...

Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson's Disease Under Rapid Response Innovation Awards 2008

... provided the head of their lab serves as administrative PI. Among the potentially high-impact Rapid Response projects funded so far this year: -- asa Abeliovich, MD, PhD, of Columbia University is working to determine whether a gene silencing technique using microRNAs -- short, noncoding molecules o...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

...patients, with an average antiplatelet therapy duration of 12.5 days. After NCS, thienopyridine administration was not restarted and 100 mg per day of asa was the only cardiac antiplatelet therapy at discharge. MACE, including in-hospital cardiac death, MI, stent thrombosis, surgical bleeding complicatio...

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

...reversible neurological damage. MLD is caused by a deficiency in the enzyme asa which causes an excess concentration of sulphatide in cells and an ensuing ...tely 2,000 MLD patients in developed world markets(1). The newly acquired asa product, currently known as METAZYM(TM), has completed a Phase Ib clinical ...

Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program

...under of GeoVax Labs, Inc. She served as Chief of Microbiology and Immunology at Emory University's Yerkes National Primate Research Center and was an asa Griggs Candler Professor of Microbiology and Immunology at the Emory University School of Medicine. Dr. Robinson is a pioneer in DNA vaccines and on...

Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned

...e Japan, Plavix(R) has shown favourable tolerability profile as compared to asa and an acceptable increase in major bleedings when used in combination with asa (no statistical difference when only PCIs are considered). In Japan, Plavi...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

...review by the EMEA was announced on July 20, 2007. The anticipated submissions for the U.S. and Japan are on schedule for later this year. During this asa annual meeting results from four additional Phase III trials were presented. About Organon Organon creates, manufactures and markets innovative pres...

MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy

...rate was 86.7% compared to 25.5% among patients treated with an initial bolus control dose of 2.0 mg/kg of Aquavan (p less than 0.001). Based upon the asa Physical Status Classification System, 31% of patients in this study were classified as P1 (having no known systemic disease), 65% were classified as ...

Viral Enzyme Recruited in Fight Against Ear Infection

...Fischetti. "This might truly be a case in which an ounce of prevention would be worth a pound of cure." Other St. Jude authors of this paper include asa Karlstrom and Amy R. Iverson (St. Jude). This work was supported in part by the United States Public Health Service and ALSAC. St. Jude Children's...

Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO

... OSLO, Norway, 30 May 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Pr...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

...an 90Y-tiuxetan-ibritumomab (Zevalin) OSLO, Norway, 14 June 2007 - Algeta asa (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that a ...rk.swallow@citigatedr.co.uk Citigate Dewe Rogerson About Algeta Algeta asa (www.algeta.com ) is a No...
Other Tags
(Date:10/1/2014)... researchers hope to take a healthy salad up a ... of breast cancer in leafy greens. , "In the ... either by eating the salad or making a pill ... of biomedical engineering at Case Western Reserve School of ... G. Komen breast cancer organization is funding the research ...
(Date:10/1/2014)... 2014 Novel detection technology ... field  The life science field has ... the years. Some are shooting stars and others ... novel detection technology that has raised much enthusiasm ... technology is becoming commercially available. With their unique ...
(Date:9/30/2014)... the Mediterranean each year, but its deep-blue waters ... Almost 1,000 alien species, including fish, crustaceans, and ... human activities. In the open-access journal Frontiers ... researchers analyzed data from a new information system ... the introduction of alien species has changed the ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3First-of-a-kind Solution for Utilizing Photon Upconversion 2Biodiversity in the Mediterranean is threatened by alien species 2
(Date:10/2/2014)... interact with stress to trigger heart disease in some people, ... about 13 percent of people, but only in those who ... heart disease risk through simple measures such as exercise, ... said. The study authors analyzed genetic data from nearly ... the EBF1 gene and higher levels of central obesity, as ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, ... the stops to rescue surgical patients in crisis are ... such heroism is questionable, a new study suggests. ... saving elderly patients with life-threatening complications after major surgery, ... senior author Dr. Amir Ghaferi. He is assistant professor ...
(Date:10/1/2014)... team of scientists has shown that more than 80 ... existing drugs. , The study found that medicines called ... a genetic mutation that is present in more than ... are currently used, or are in clinical trials, for ... disorders. , Bowel cancer is the second-most common cancer ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... October 01, 2014 Bedros Keuilian is ... Boot Camp fitness boot camps, he’s also considered the ... , with sold out business summits, a line of ... consultant to a recent Spike TV reality show to ... now is the time for personal trainers and fitness ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
Other Contents